DaCapo Brainscience develops disease-modifying therapies for neurodegenerative diseases, focusing on innovative treatments.
DaCapo Brainscience has raised $20.0M in total funding. The most recent round was Seed. The last funding was announced in June 2025.
DaCapo Brainscience's investors include DNS Capital.
DaCapo Brainscience is headquartered in Cambridge, United States.
DaCapo Brainscience develops disease-modifying therapies for neurodegenerative diseases, focusing on innovative treatments.
DaCapo Brainscience is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"DaCapo Brainscience — Funding & Investors." VCBacked, June 30, 2025, https://www.vcbacked.co/company/dacapo-brainscience. Accessed September 30, 2026.
VCBacked. (2025). DaCapo Brainscience — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/dacapo-brainscience
{{cite web |title=DaCapo Brainscience — Funding & Investors |url=https://www.vcbacked.co/company/dacapo-brainscience |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated